FDA Part 11 Starts With Your Data, Not Your Paperwork
When an FDA auditor, a commercial partner's due diligence team, or your next round's investors come asking, the question is the same: can you prove your electronic records and signatures are complete, attributable, and tamper-evident? 21 CFR Part 11 and GxP data integrity rest on audit trails you can produce on demand, and HIPAA applies the moment clinical or patient data is in the mix. Amoeba Networks builds and runs the systems behind that evidence for biotech and medical device startups across the New York Metro and the Puget Sound Area.
Your research data, lab pipelines, and IP are the company. We treat them as production systems, with the controls and recovery to back that up, so a missing log entry or an unsecured file share never becomes the reason a raise stalls or an audit slips.